LPL Financial’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $954K | Buy |
46,533
+4,741
| +11% | +$97.2K | ﹤0.01% | 3768 |
|
|
2025
Q1 | $856K | Buy |
41,792
+2,875
| +7% | +$58.9K | ﹤0.01% | 3648 |
|
|
2024
Q4 | $881K | Sell |
38,917
-3,885
| -9% | -$87.9K | ﹤0.01% | 3562 |
|
|
2024
Q3 | $1.05M | Sell |
42,802
-4,637
| -10% | -$114K | ﹤0.01% | 3307 |
|
|
2024
Q2 | $1.1M | Sell |
47,439
-1,362
| -3% | -$31.5K | ﹤0.01% | 3124 |
|
|
2024
Q1 | $1.18M | Sell |
48,801
-5,291
| -10% | -$127K | ﹤0.01% | 3001 |
|
|
2023
Q4 | $1.24M | Buy |
54,092
+656
| +1% | +$15.1K | ﹤0.01% | 2838 |
|
|
2023
Q3 | $1.09M | Sell |
53,436
-168
| -0.3% | -$3.42K | ﹤0.01% | 2805 |
|
|
2023
Q2 | $1.25M | Sell |
53,604
-16,339
| -23% | -$382K | ﹤0.01% | 2645 |
|
|
2023
Q1 | $1.63M | Buy |
69,943
+2,790
| +4% | +$64.9K | ﹤0.01% | 2312 |
|
|
2022
Q4 | $1.69M | Sell |
67,153
-10,202
| -13% | -$257K | ﹤0.01% | 2198 |
|
|
2022
Q3 | $2.04M | Buy |
77,355
+1,088
| +1% | +$28.7K | ﹤0.01% | 1962 |
|
|
2022
Q2 | $2.2M | Buy |
76,267
+3,304
| +5% | +$95.5K | ﹤0.01% | 1947 |
|
|
2022
Q1 | $2.51M | Sell |
72,963
-32,526
| -31% | -$1.12M | ﹤0.01% | 1869 |
|
|
2021
Q4 | $4.62M | Buy |
105,489
+4,420
| +4% | +$194K | ﹤0.01% | 1506 |
|
|
2021
Q3 | $5.13M | Sell |
101,069
-10,772
| -10% | -$546K | ﹤0.01% | 1369 |
|
|
2021
Q2 | $5.82M | Buy |
111,841
+3,218
| +3% | +$167K | 0.01% | 1235 |
|
|
2021
Q1 | $4.97M | Buy |
108,623
+27,622
| +34% | +$1.26M | 0.01% | 1230 |
|
|
2020
Q4 | $3.72M | Buy |
81,001
+44,416
| +121% | +$2.04M | ﹤0.01% | 1277 |
|
|
2020
Q3 | $1.43M | Buy |
36,585
+23,601
| +182% | +$919K | ﹤0.01% | 1657 |
|
|
2020
Q2 | $493K | Buy |
+12,984
| New | +$493K | ﹤0.01% | 2380 |
|